SK280304B6 - Liečivo na kardiálnu, ako i vaskulárnu hypertrofiu - Google Patents
Liečivo na kardiálnu, ako i vaskulárnu hypertrofiu Download PDFInfo
- Publication number
- SK280304B6 SK280304B6 SK3471-91A SK347191A SK280304B6 SK 280304 B6 SK280304 B6 SK 280304B6 SK 347191 A SK347191 A SK 347191A SK 280304 B6 SK280304 B6 SK 280304B6
- Authority
- SK
- Slovakia
- Prior art keywords
- methyl
- butyl
- chloro
- biphenyl
- imidazole
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Recrystallisation Techniques (AREA)
- Compounds Of Unknown Constitution (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4036706A DE4036706A1 (de) | 1990-11-17 | 1990-11-17 | Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie |
Publications (1)
Publication Number | Publication Date |
---|---|
SK280304B6 true SK280304B6 (sk) | 1999-11-08 |
Family
ID=6418475
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK3471-91A SK280304B6 (sk) | 1990-11-17 | 1991-11-15 | Liečivo na kardiálnu, ako i vaskulárnu hypertrofiu |
Country Status (20)
Country | Link |
---|---|
US (1) | US5236943A (ko) |
EP (1) | EP0492105B1 (ko) |
JP (1) | JP3370347B2 (ko) |
KR (1) | KR100221686B1 (ko) |
CN (1) | CN1049116C (ko) |
AT (1) | ATE108656T1 (ko) |
AU (1) | AU652590B2 (ko) |
BR (1) | BR9104918A (ko) |
CA (1) | CA2055637C (ko) |
CZ (1) | CZ283236B6 (ko) |
DE (2) | DE4036706A1 (ko) |
DK (1) | DK0492105T3 (ko) |
ES (1) | ES2060274T3 (ko) |
HR (1) | HRP940765B1 (ko) |
HU (1) | HU219404B (ko) |
IE (1) | IE66461B1 (ko) |
MX (1) | MX9102100A (ko) |
NO (1) | NO914482L (ko) |
SK (1) | SK280304B6 (ko) |
ZA (1) | ZA919056B (ko) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6034114A (en) * | 1990-12-14 | 2000-03-07 | Smithkline Beecham Plc | Medicament |
US5616599A (en) * | 1991-02-21 | 1997-04-01 | Sankyo Company, Limited | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
US5264447A (en) * | 1992-09-01 | 1993-11-23 | Merck & Co., Inc. | Angiotensin II antagonist |
US5266583A (en) * | 1992-09-01 | 1993-11-30 | Merck & Co., Inc. | Angitotensin II antagonist |
JP3501484B2 (ja) * | 1992-12-17 | 2004-03-02 | 三共株式会社 | ビフェニル誘導体 |
US5908858A (en) | 1996-04-05 | 1999-06-01 | Sankyo Company, Limited | 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses |
CA2273836A1 (en) * | 1996-12-10 | 1998-06-18 | G.D. Searle & Co. | Substituted pyrrolyl compounds for the treatment of inflammation |
AU6320998A (en) | 1997-02-21 | 1998-09-09 | Bristol-Myers Squibb Company | Benzoic acid derivatives and related compounds as antiarrhythmic agents |
ES2154191B1 (es) * | 1998-11-24 | 2001-10-16 | Ferrer Int | Nuevos acetales derivados de los 2-alquil-5-halo-3-(2'-(tetrazol-5-il)-bifenil-4-ilmetil)-3h-imidazol-4-carbaldehidos. |
SE9903028D0 (sv) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
US6740649B2 (en) | 2001-09-17 | 2004-05-25 | Bristol-Myers Squibb Company | Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- α converting enzyme (TACE) |
ITTO20040264A1 (it) * | 2004-04-28 | 2004-07-28 | Rotta Res Lab Spa | Nuovi derivati pirrolici ad attivita' angiotensina-ii antagonista |
KR100953878B1 (ko) * | 2004-09-02 | 2010-04-22 | 테바 파마슈티컬 인더스트리즈 리미티드 | 올메살탄 메독소밀의 정제 |
US20070054948A1 (en) * | 2004-09-02 | 2007-03-08 | Lilach Hedvati | Purification of olmesartan medoxomil |
CN1976926A (zh) * | 2004-09-02 | 2007-06-06 | 特瓦制药工业有限公司 | 奥美沙坦酯的制备 |
US20060258727A1 (en) * | 2005-01-03 | 2006-11-16 | Lilach Hedvati | Olmesartan medoxomil with reduced levels of impurities |
EP2170062A4 (en) | 2007-07-12 | 2010-12-29 | Tragara Pharmaceuticals Inc | METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER DISORDERS, TUMORS AND TUMOR-DISORDED DISEASES |
DK2315590T3 (da) | 2008-08-15 | 2012-11-19 | N30 Pharmaceuticals Inc | Pyrrolinhibitorer af S-nitrosoglutathionreduktase |
JP2012500216A (ja) | 2008-08-15 | 2012-01-05 | エヌサーティー・ファーマシューティカルズ,エルエルシー | 治療薬剤としての、s−ニトロソグルタチオンレダクターゼの新規ピロール阻害剤 |
DK2318007T3 (da) * | 2008-08-15 | 2013-03-25 | N30 Pharmaceuticals Inc | Nye pyrrol-inhibitorer af s-nitrosoglutathion-reduktase som terapeutiske midler |
CN102816126A (zh) * | 2011-06-07 | 2012-12-12 | 中国药科大学 | 具有心血管活性的胺磺酰芳基取代的三氮唑类衍生物、其制备方法及用途 |
WO2020113094A1 (en) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US488084A (en) * | 1892-12-13 | Blank-feeding device | ||
JPS5671073A (en) * | 1979-11-12 | 1981-06-13 | Takeda Chem Ind Ltd | Imidazole derivative |
JPS5671074A (en) * | 1979-11-12 | 1981-06-13 | Takeda Chem Ind Ltd | 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative |
US4820843A (en) * | 1987-05-22 | 1989-04-11 | E. I. Du Pont De Nemours And Company | Tetrazole intermediates to antihypertensive compounds |
US5015651A (en) * | 1988-01-07 | 1991-05-14 | E. I. Du Pont De Nemours And Company | Treatment of hypertension with 1,2,4-angiotensin II antagonists |
CA1338238C (en) * | 1988-01-07 | 1996-04-09 | David John Carini | Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids |
US4880804A (en) * | 1988-01-07 | 1989-11-14 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking benzimidazoles |
GB8820844D0 (en) * | 1988-09-05 | 1988-10-05 | Pfizer Ltd | Therapeutic agents |
US4916129A (en) * | 1989-01-19 | 1990-04-10 | E. I. Du Pont De Nemours And Company | Combination β-blocking/angiotensin II blocking antihypertensives |
IL95975A (en) * | 1989-10-24 | 1997-06-10 | Takeda Chemical Industries Ltd | N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them |
DE4010797A1 (de) * | 1990-04-04 | 1991-10-10 | Hoechst Ag | Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung |
US5196444A (en) * | 1990-04-27 | 1993-03-23 | Takeda Chemical Industries, Ltd. | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
DE4023215A1 (de) * | 1990-07-21 | 1992-01-23 | Hoechst Ag | Substituierte azole, verfahren zu deren herstellung, sie enthaltende mittel und deren verwendung |
DE4036645A1 (de) * | 1990-11-16 | 1992-05-21 | Hoechst Ag | Substituierte azole, verfahren zu deren herstellung, deren enthaltende mittel und deren verwendung |
-
1990
- 1990-11-17 DE DE4036706A patent/DE4036706A1/de not_active Withdrawn
-
1991
- 1991-11-11 ES ES91119183T patent/ES2060274T3/es not_active Expired - Lifetime
- 1991-11-11 DK DK91119183.1T patent/DK0492105T3/da active
- 1991-11-11 EP EP91119183A patent/EP0492105B1/de not_active Expired - Lifetime
- 1991-11-11 AT AT91119183T patent/ATE108656T1/de not_active IP Right Cessation
- 1991-11-11 DE DE59102259T patent/DE59102259D1/de not_active Expired - Lifetime
- 1991-11-13 BR BR919104918A patent/BR9104918A/pt unknown
- 1991-11-14 US US07/791,501 patent/US5236943A/en not_active Expired - Lifetime
- 1991-11-15 HU HU581/91A patent/HU219404B/hu unknown
- 1991-11-15 ZA ZA919056A patent/ZA919056B/xx unknown
- 1991-11-15 IE IE399291A patent/IE66461B1/en not_active IP Right Cessation
- 1991-11-15 AU AU87858/91A patent/AU652590B2/en not_active Expired
- 1991-11-15 MX MX9102100A patent/MX9102100A/es unknown
- 1991-11-15 NO NO91914482A patent/NO914482L/no unknown
- 1991-11-15 SK SK3471-91A patent/SK280304B6/sk not_active IP Right Cessation
- 1991-11-15 KR KR1019910020342A patent/KR100221686B1/ko not_active IP Right Cessation
- 1991-11-15 CA CA002055637A patent/CA2055637C/en not_active Expired - Lifetime
- 1991-11-15 JP JP32666391A patent/JP3370347B2/ja not_active Expired - Lifetime
- 1991-11-15 CZ CS913471A patent/CZ283236B6/cs not_active IP Right Cessation
- 1991-11-16 CN CN91110817A patent/CN1049116C/zh not_active Expired - Lifetime
-
1994
- 1994-10-25 HR HR940765A patent/HRP940765B1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE108656T1 (de) | 1994-08-15 |
HU219404B (hu) | 2001-04-28 |
HRP940765B1 (en) | 2000-08-31 |
BR9104918A (pt) | 1992-06-23 |
IE913992A1 (en) | 1992-05-20 |
KR100221686B1 (ko) | 1999-09-15 |
KR920009393A (ko) | 1992-06-25 |
DE4036706A1 (de) | 1992-05-21 |
IE66461B1 (en) | 1995-12-27 |
NO914482D0 (no) | 1991-11-15 |
JP3370347B2 (ja) | 2003-01-27 |
DK0492105T3 (da) | 1994-11-07 |
EP0492105A2 (de) | 1992-07-01 |
DE59102259D1 (de) | 1994-08-25 |
HRP940765A2 (en) | 1997-08-31 |
EP0492105A3 (en) | 1992-07-29 |
AU8785891A (en) | 1992-05-21 |
JPH04290823A (ja) | 1992-10-15 |
US5236943A (en) | 1993-08-17 |
ZA919056B (en) | 1992-07-29 |
HU913581D0 (en) | 1992-01-28 |
HUT59599A (en) | 1992-06-29 |
CN1049116C (zh) | 2000-02-09 |
CA2055637A1 (en) | 1992-05-18 |
EP0492105B1 (de) | 1994-07-20 |
CA2055637C (en) | 2003-11-11 |
AU652590B2 (en) | 1994-09-01 |
CS347191A3 (en) | 1992-06-17 |
NO914482L (no) | 1992-05-18 |
MX9102100A (es) | 1992-07-08 |
CZ283236B6 (cs) | 1998-02-18 |
ES2060274T3 (es) | 1994-11-16 |
CN1062289A (zh) | 1992-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK280304B6 (sk) | Liečivo na kardiálnu, ako i vaskulárnu hypertrofiu | |
US3980791A (en) | Tetramisole and levamisole pour-on anthelmintic compositions and methods of use | |
EP0628313B1 (en) | Combination of an angiotensin-II antagonising benzimidazole with manidipine for the treatment of hypertension | |
JP2930252B2 (ja) | アンジオテンシン−▲ii▼受容体拮抗剤およびカルシウムチャンネルブロッカーの新規組成物 | |
JP2011256195A (ja) | 虚血後腎不全の予防および処置並びに虚血腎臓の保護のためのat1−レセプターアンタゴニスト | |
JP2002537258A (ja) | 高血圧の治療のための医薬 | |
RU2367442C2 (ru) | Способ нормализации мочеиспускания при нарушении функции почек | |
EP0426066A2 (en) | Ace inhibitors for use for preventing onset of type II diabetes | |
DE69821252T2 (de) | Verwendung eines Angiotensin-II Antagonisten zur Herstellung von Arzneistoffen zur Erhöhung der Überlebensrate von Nierentransplantationspatienten | |
EP0660713B1 (en) | Use of angiotensin ii antagonists in the treatment of left ventricular hypertrophy | |
US5466713A (en) | Iloprost with action against cerebral malaria | |
SK74995A3 (en) | Antihyperglicemicly efficient pharmaceutical agents | |
CZ290155B6 (cs) | Léčivo pro léčení několikanásobné poruchy systémových orgánů | |
US8455526B2 (en) | Therapeutic use of imidazole-5-carboxylic acid derivatives | |
EA007952B1 (ru) | Применение ирбесартана для изготовления лекарств, которые пригодны для предупреждения или лечения лёгочной артериальной гипертензии | |
SK78994A3 (en) | Optic hypotensive agent and method of its preparation | |
DE69430766T2 (de) | Vasculäre Hypertrophicsuppressor | |
JPH0532635A (ja) | ヒスタミン誘導体の治療への応用と、新規なヒスタミン誘導体と、この誘導体の医薬としての使用 | |
DK166755B1 (da) | Farmaceutisk praeparat indeholdende en angiotensin-omdannende enzym-inhibitor og et sloejfediuretikum og fremgamgsmaade til fremstilling af praeparatet | |
EP0439320A1 (en) | Erectile dysfunction treatment | |
AU774855B2 (en) | Use of moxonidine for postmyocardial infarction treatment | |
KR100222627B1 (ko) | 앙기오텐신-ii 수용체 길항제 및 칼슘 채널 차단제의 신규한 조성물 | |
JP2949366B2 (ja) | 心臓疾患の予防または治療剤 | |
US20040048776A1 (en) | Medicament for preventive and therapeutic treatment of fibrosis | |
KR20010013014A (ko) | 고립성 수축기 고혈압증의 치료 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4A | Patent expired |
Expiry date: 20111115 |